Blood sugar control and rheumatoid arthritis activity in people with diabetes
Studies how blood sugar control relates to rheumatoid arthritis activity in adults with diabetes.
Key facts
- Who runs it
- Assiut University
- Where
- Asyut, EgyptSee the site
- Trial code
- Registry title
- The Impact of Glycemic Control on Rheumatoid Arthritis Disease Activity on Diabetic Patients
- Status
- Not yet recruiting
- People taking part
- 100 people, planned
- Started
- 12 Dec 2024
- Expected to end
- 1 Jun 2027
- Type of study
- Observational
- Record updated
- 18 November 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with both rheumatoid arthritis and type 2 diabetes. It studies how blood sugar control relates to arthritis activity.
- Age
- 18 to 65 years
- Sex
- All sexes can join.
- Disease stage
- Rheumatoid arthritis together with type 2 diabetes.
Main reasons for not taking part
- Gestational diabetes
- Type 1 diabetes
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- type 2 diabetic patients
- rheumatoid arthritis patients
Who cannot take part
- gestional diabetes
- type 1 diabetic patients
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in Egypt
- Assiut UniversityAsyut, EgyptContact: Ahmed khedr NadyNo longer taking part
About the trial
What the trial wants to find out
The incidence of DM is unclear in RA but most prior data suggest that DM or insulin resistance in RA has risen because of activation of the immune system and/or RA therapy .
Read full original descriptionShow less
Besides, RA causes joints to become stiff, swollen, and agonizing. As a result, the patient may not want to exercise or move. One study found that 42% of people with RA are not physically active. the aim of this study is To evaluate the glycemic status among RA patients with Type 2 diabetes and its association with disease activity.
The group in the trial
- group 1
RA patients with Type 2 diabetes
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- The Impact of Glycemic Control on Rheumatoid Arthritis Disease Activity in Diabetic Patients
- Plain-language title
- Blood sugar control and rheumatoid arthritis activity in people with diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06691997, who can take part
- Record updated
- 18 November 2024